Computational Structural Validation of CYP2C9 Mutations and Evaluation of Machine Learning Algorithms in Predicting the Therapeutic Outcomes of Warfarin
The study aimed to identify the key pharmacogenetic variable influencing the therapeutic outcomes of warfarin using machine learning algorithms and bioinformatics tools. Warfarin, a commonly used anticoagulant drug, is influenced by cytochrome P450 (CYP) enzymes, particularly CYP2C9. MLAs have been...
Gespeichert in:
| Veröffentlicht in: | Current drug metabolism Jg. 24; H. 6; S. 466 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Netherlands
01.01.2023
|
| Schlagworte: | |
| ISSN: | 1875-5453, 1875-5453 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The study aimed to identify the key pharmacogenetic variable influencing the therapeutic outcomes of warfarin using machine learning algorithms and bioinformatics tools.
Warfarin, a commonly used anticoagulant drug, is influenced by cytochrome P450 (CYP) enzymes, particularly CYP2C9. MLAs have been identified to have great potential in personalized therapy.
The purpose of the study was to evaluate MLAs in predicting the critical outcomes of warfarin therapy and validate the key predictor genotyping variable using bioinformatics tools.
An observational study was conducted on adults receiving warfarin. Allele discrimination method was used for estimating the single nucleotide polymorphisms (SNPs) in CYP2C9, VKORC1, and CYP4F2. MLAs were used for identifying the significant genetic and clinical variables in predicting the poor anticoagulation status (ACS) and stable warfarin dose. Advanced computational methods (SNPs' deleteriousness and impact on protein destabilization, molecular dockings, and 200ns molecular dynamics simulations) were employed for examining the influence of CYP2C9 SNPs on structure and function.
Machine learning algorithms revealed CYP2C9 to be the most important predictor for both outcomes compared to the classical methods. Computational validation confirmed the altered structural activity, stability, and impaired functions of protein products of CYP2C9 SNPs. Molecular docking and dynamics simulations revealed significant conformational changes with mutations R144C and I359L in CYP2C9.
We evaluated various MLAs in predicting the critical outcome measures associated with warfarin and observed CYP2C9 as the most critical predictor variable. The results of our study provide insight into the molecular basis of warfarin and the CYP2C9 gene. A prospective study validating the MLAs is urgently needed. |
|---|---|
| AbstractList | The study aimed to identify the key pharmacogenetic variable influencing the therapeutic outcomes of warfarin using machine learning algorithms and bioinformatics tools.AIMThe study aimed to identify the key pharmacogenetic variable influencing the therapeutic outcomes of warfarin using machine learning algorithms and bioinformatics tools.Warfarin, a commonly used anticoagulant drug, is influenced by cytochrome P450 (CYP) enzymes, particularly CYP2C9. MLAs have been identified to have great potential in personalized therapy.BACKGROUNDWarfarin, a commonly used anticoagulant drug, is influenced by cytochrome P450 (CYP) enzymes, particularly CYP2C9. MLAs have been identified to have great potential in personalized therapy.The purpose of the study was to evaluate MLAs in predicting the critical outcomes of warfarin therapy and validate the key predictor genotyping variable using bioinformatics tools.OBJECTIVEThe purpose of the study was to evaluate MLAs in predicting the critical outcomes of warfarin therapy and validate the key predictor genotyping variable using bioinformatics tools.An observational study was conducted on adults receiving warfarin. Allele discrimination method was used for estimating the single nucleotide polymorphisms (SNPs) in CYP2C9, VKORC1, and CYP4F2. MLAs were used for identifying the significant genetic and clinical variables in predicting the poor anticoagulation status (ACS) and stable warfarin dose. Advanced computational methods (SNPs' deleteriousness and impact on protein destabilization, molecular dockings, and 200 ns molecular dynamics simulations) were employed for examining the influence of CYP2C9 SNPs on structure and function.METHODSAn observational study was conducted on adults receiving warfarin. Allele discrimination method was used for estimating the single nucleotide polymorphisms (SNPs) in CYP2C9, VKORC1, and CYP4F2. MLAs were used for identifying the significant genetic and clinical variables in predicting the poor anticoagulation status (ACS) and stable warfarin dose. Advanced computational methods (SNPs' deleteriousness and impact on protein destabilization, molecular dockings, and 200 ns molecular dynamics simulations) were employed for examining the influence of CYP2C9 SNPs on structure and function.Machine learning algorithms revealed CYP2C9 to be the most important predictor for both outcomes compared to the classical methods. Computational validation confirmed the altered structural activity, stability, and impaired functions of protein products of CYP2C9 SNPs. Molecular docking and dynamics simulations revealed significant conformational changes with mutations R144C and I359L in CYP2C9.RESULTSMachine learning algorithms revealed CYP2C9 to be the most important predictor for both outcomes compared to the classical methods. Computational validation confirmed the altered structural activity, stability, and impaired functions of protein products of CYP2C9 SNPs. Molecular docking and dynamics simulations revealed significant conformational changes with mutations R144C and I359L in CYP2C9.We evaluated various MLAs in predicting the critical outcome measures associated with warfarin and observed CYP2C9 as the most critical predictor variable. The results of our study provide insight into the molecular basis of warfarin and the CYP2C9 gene. A prospective study validating the MLAs is urgently needed.CONCLUSIONWe evaluated various MLAs in predicting the critical outcome measures associated with warfarin and observed CYP2C9 as the most critical predictor variable. The results of our study provide insight into the molecular basis of warfarin and the CYP2C9 gene. A prospective study validating the MLAs is urgently needed. The study aimed to identify the key pharmacogenetic variable influencing the therapeutic outcomes of warfarin using machine learning algorithms and bioinformatics tools. Warfarin, a commonly used anticoagulant drug, is influenced by cytochrome P450 (CYP) enzymes, particularly CYP2C9. MLAs have been identified to have great potential in personalized therapy. The purpose of the study was to evaluate MLAs in predicting the critical outcomes of warfarin therapy and validate the key predictor genotyping variable using bioinformatics tools. An observational study was conducted on adults receiving warfarin. Allele discrimination method was used for estimating the single nucleotide polymorphisms (SNPs) in CYP2C9, VKORC1, and CYP4F2. MLAs were used for identifying the significant genetic and clinical variables in predicting the poor anticoagulation status (ACS) and stable warfarin dose. Advanced computational methods (SNPs' deleteriousness and impact on protein destabilization, molecular dockings, and 200ns molecular dynamics simulations) were employed for examining the influence of CYP2C9 SNPs on structure and function. Machine learning algorithms revealed CYP2C9 to be the most important predictor for both outcomes compared to the classical methods. Computational validation confirmed the altered structural activity, stability, and impaired functions of protein products of CYP2C9 SNPs. Molecular docking and dynamics simulations revealed significant conformational changes with mutations R144C and I359L in CYP2C9. We evaluated various MLAs in predicting the critical outcome measures associated with warfarin and observed CYP2C9 as the most critical predictor variable. The results of our study provide insight into the molecular basis of warfarin and the CYP2C9 gene. A prospective study validating the MLAs is urgently needed. |
| Author | Kumar, Thirumal Sridharan, Kannan Al Banna, Rashed Prasanna, Gaurav Manikandan, Suchetha Doss, George Priya G, Lalitha |
| Author_xml | – sequence: 1 givenname: Kannan orcidid: 0000-0003-3811-6503 surname: Sridharan fullname: Sridharan, Kannan organization: Department of Pharmacology & Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain – sequence: 2 givenname: Thirumal surname: Kumar fullname: Kumar, Thirumal organization: Faculty of Allied Health Sciences, Meenakshi Academy of Higher Education and Research, Chennai, Tamil Nadu, India – sequence: 3 givenname: Suchetha surname: Manikandan fullname: Manikandan, Suchetha organization: Centre for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology, Chennai, India – sequence: 4 givenname: Gaurav surname: Prasanna fullname: Prasanna, Gaurav organization: Centre for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology, Chennai, India – sequence: 5 givenname: Lalitha surname: G fullname: G, Lalitha organization: Centre for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology, Chennai, India – sequence: 6 givenname: Rashed surname: Al Banna fullname: Al Banna, Rashed organization: Department of Cardiology, Salmaniya Medical Complex, Manama, Kingdom of Bahrain – sequence: 7 givenname: George Priya surname: Doss fullname: Doss, George Priya organization: School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, India |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37409551$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkM1KAzEUhYMoWquvIHHnppq5SSYzyzL4By0WrIqrkmSSNjCTqZlE8E18XFut4t2cwzkfZ3GP0b7vvEHoPCOXkAl2ldGiBEIAWJ7nQIkgPANGodxDg6wQfMQZp_v__CE6ooKRkvNsgD6rrl2nKKPrvGzwYwxJxxQ29lk2rv7OcWdx9TqDqsTTHdpj6Wt8_S6b9IdMpV45b_DEyOCdX-Jxs-yCi6u2x87jWTC103FbxJXB85UJcm1SdBo_pKi71vTblRcZrAzOn6ADK5venO50iJ5urufV3WjycHtfjScjxTjEkVJFUSsrqOWgNSW2FMIKlVEjrbJFyfM6p6JmtDS0rCEvCFghTA6KK1YoDUN08bO7Dt1bMn1ctK7XpmmkN13qF1BQRjZHYYOe7dCkWlMv1sG1Mnwsfr8JXzN-emI |
| ContentType | Journal Article |
| Copyright | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| Copyright_xml | – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| DBID | NPM 7X8 |
| DOI | 10.2174/1389200224666230705124329 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1875-5453 |
| ExternalDocumentID | 37409551 |
| Genre | Journal Article |
| GroupedDBID | NPM 7X8 |
| ID | FETCH-LOGICAL-b452t-bb88dbf73f52cc30f977f7b13eafbf8956d637d439e39d26802f77e62b5b48bc2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001069595400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1875-5453 |
| IngestDate | Fri Jul 11 12:16:27 EDT 2025 Thu Jan 02 22:52:07 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | CYP2C9 Warfarin Support vector machine Molecular Dynamics Simulation Machine learning algorithm |
| Language | English |
| License | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b452t-bb88dbf73f52cc30f977f7b13eafbf8956d637d439e39d26802f77e62b5b48bc2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-3811-6503 |
| PMID | 37409551 |
| PQID | 2834000032 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2834000032 pubmed_primary_37409551 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-01 |
| PublicationDateYYYYMMDD | 2023-01-01 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Current drug metabolism |
| PublicationTitleAlternate | Curr Drug Metab |
| PublicationYear | 2023 |
| Score | 2.364143 |
| Snippet | The study aimed to identify the key pharmacogenetic variable influencing the therapeutic outcomes of warfarin using machine learning algorithms and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 466 |
| Title | Computational Structural Validation of CYP2C9 Mutations and Evaluation of Machine Learning Algorithms in Predicting the Therapeutic Outcomes of Warfarin |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37409551 https://www.proquest.com/docview/2834000032 |
| Volume | 24 |
| WOSCitedRecordID | wos001069595400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDI6AIcSFh3iNlzKJa7Qt6Zr0hKZpEwc2KjHGOE1Nm4xJ0I6147fwc7Hbjt0QEpee0ipNHPuz_cUm5EbIhpGhATfVMR5zpKuZtjpiAuyBCVxhVE4eH93LwUCNx55fBtzSkla50om5oo6SEGPkdTCDDipXwW_nHwy7RmF2tWyhsUkqAqAMHkw5zm-_AQxnAA7EDqkh2xlwdx1Tcjy3WQDZkf8M8sgd8Ru4zI1Mb_-_0zsgeyW8pO1CHg7JhomPyFfRuqEM-9HHvGQsltugI0DhRVMlmljaefF5x6P9cmhKgzii3Z9y4Dikn3MvDS3Lsk5p-20K08he31M6i6m_wLwPMqkpAEs6XF_uog_LDP7EpPiV52BhwUePj8lTrzvs3LGyIwPTTotnTGulIm2lsC0ehqJhAT1aqZvCBFZbBb5W5AoZAcgxwou4qxrcSmlcrlvaUTrkJ2QrTmJzRqi0QqrQNq3EDdGhkp4bmQDwpdLCc50qqa0WegISj2mMIDbJMp2sl7pKTovdmsyL0hwTIR2sqdc8_8PbF2QXe8cX8ZRLUrFw3s0V2Q4_s1m6uM5FCZ4Dv_8NymbVsQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Computational+Structural+Validation+of+CYP2C9+Mutations+and+Evaluation+of+Machine+Learning+Algorithms+in+Predicting+the+Therapeutic+Outcomes+of+Warfarin&rft.jtitle=Current+drug+metabolism&rft.au=Sridharan%2C+Kannan&rft.au=Kumar%2C+Thirumal&rft.au=Manikandan%2C+Suchetha&rft.au=Prasanna%2C+Gaurav&rft.date=2023-01-01&rft.eissn=1875-5453&rft_id=info:doi/10.2174%2F1389200224666230705124329&rft_id=info%3Apmid%2F37409551&rft_id=info%3Apmid%2F37409551&rft.externalDocID=37409551 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1875-5453&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1875-5453&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1875-5453&client=summon |